BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23818135)

  • 1. Progress in the identification of plasma biomarkers of colorectal cancer.
    Coghlin C; Murray GI
    Proteomics; 2013 Aug; 13(15):2227-8. PubMed ID: 23818135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients.
    Choi JW; Liu H; Shin DH; Yu GI; Hwang JS; Kim ES; Yun JW
    Proteomics; 2013 Aug; 13(15):2361-74. PubMed ID: 23606366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hierarchical classifier based on human blood plasma fluorescence for non-invasive colorectal cancer screening.
    Soares F; Becker K; Anzanello MJ
    Artif Intell Med; 2017 Oct; 82():1-10. PubMed ID: 28939302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia.
    Kontovounisios C; Qiu S; Rasheed S; Darzi A; Tekkis P
    Updates Surg; 2017 Sep; 69(3):397-402. PubMed ID: 28560510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA11-19: a tumor marker for the detection of colorectal cancer.
    Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
    Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.
    Castiella A; Múgica F; Zapata E; Zubiaurre L; Iribarren A; de Juan MD; Alzate L; Gil I; Urdapilleta G; Otazua P; Emparanza JI
    Tumour Biol; 2015 Sep; 36(9):6959-63. PubMed ID: 25854174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
    Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
    PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening.
    Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
    J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
    Johdi NA; Mazlan L; Sagap I; Jamal R
    Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.
    Ciarloni L; Ehrensberger SH; Imaizumi N; Monnier-Benoit S; Nichita C; Myung SJ; Kim JS; Song SY; Kim TI; van der Weg B; Meier R; Borovicka J; Beglinger C; Vallet C; Maerten P; Rüegg C; Dorta G
    Clin Cancer Res; 2016 Sep; 22(18):4604-11. PubMed ID: 27126992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.
    Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH
    Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for early detection of colorectal cancer and polyps: systematic review.
    Shah R; Jones E; Vidart V; Kuppen PJ; Conti JA; Francis NK
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1712-28. PubMed ID: 25004920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study.
    Mihas AA; Maliakkal RJ; Shueke M; Achord JL
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):301-4. PubMed ID: 8747797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
    Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
    Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
    Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.